Itapira, Brazil

Thiago Boscaro Vernucci



Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thiago Boscaro Vernucci: Innovator in HIV Treatment

Introduction

Thiago Boscaro Vernucci is a notable inventor based in Itapira, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating HIV. His innovative work has the potential to improve the lives of many individuals affected by this virus.

Latest Patents

Vernucci holds a patent for a ritonavir analogous compound that serves as a retroviral protease inhibitor. This invention describes a new ritonavir analogous compound that exhibits significantly superior activity in inhibiting HIV protease. The patent also details the preparation of this compound and its pharmaceutical compositions, which can be used in medicine, especially for the treatment of HIV infection, either alone or in combination with other anti-HIV drugs. He has 1 patent to his name.

Career Highlights

Vernucci is associated with Cristalia Produtos Quimicos Farmaceuticos Ltda., where he applies his expertise in pharmaceutical chemistry. His work at Cristalia has allowed him to focus on innovative solutions for complex medical challenges, particularly in the realm of viral infections.

Collaborations

Throughout his career, Vernucci has collaborated with talented professionals, including Maria Alice Bockelmann and Simone Rosatto. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Thiago Boscaro Vernucci is a dedicated inventor whose work in developing HIV treatment compounds showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against HIV, and his innovative spirit continues to inspire others in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…